NAM
VRTX icon

NorthCrest Asset Manangement’s Vertex Pharmaceuticals VRTX Stock Holding History

NorthCrest Asset Manangement’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772K Buy
1,554
+498
+47% +$221K 0.02% 433
2026
Q1 		$463K Sell
1,056
-39
-4% -$18.2K 0.01% 503
2025
Q4 		$492K Sell
1,095
-271
-20% -$117K 0.01% 544
2025
Q3 		$560K Sell
1,366
-14
-1% -$5.85K 0.01% 466
2025
Q2 		$634K Sell
1,380
-9
-0.6% -$4.15K 0.02% 375
2025
Q1 		$673K Buy
1,389
+96
+7% +$44.7K 0.02% 370
2024
Q4 		$521K Sell
1,293
-125
-9% -$57.9K 0.02% 389
2024
Q3 		$660K Buy
1,418
+188
+15% +$90.3K 0.02% 360
2024
Q2 		$577K Buy
1,230
+294
+31% +$128K 0.02% 360
2024
Q1 		$391K Buy
936
+107
+13% +$45.2K 0.01% 413
2023
Q4 		$337K Sell
829
-451
-35% -$167K 0.01% 437
2023
Q3 		$445K Sell
1,280
-14
-1% -$4.9K 0.02% 385
2023
Q2 		$455K Buy
1,294
+6
+0.5% +$2.02K 0.02% 376
2023
Q1 		$406K Sell
1,288
-23
-2% -$6.9K 0.02% 399
2022
Q4 		$379K Buy
+1,311
New +$400K 0.02% 329

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

NorthCrest Asset Manangement's VRTX Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Vertex Pharmaceuticals (VRTX) stake by 47% in Q2 2026, buying an estimated $221K and bringing the position to 1,554 shares worth $772K. The position accounts for 0.02% of the portfolio, ranked #433.

NorthCrest Asset Manangement first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • NorthCrest Asset Manangement held 1,554 shares of Vertex Pharmaceuticals worth $772K as of Q2 2026.
  • NorthCrest Asset Manangement bought 498 Vertex Pharmaceuticals shares in Q2 2026, an estimated $221K.
  • Vertex Pharmaceuticals made up 0.02% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #433 holding.
  • NorthCrest Asset Manangement first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.